Company: PCRX
Filing Date: 2025-02-27
Form Type: 10-K
Source: 0001396814-25-000041
Chunk: 103

Company: Pacira BioSciences, Inc.
Filing Date: 2025-02-27
Form: 10-K
Item: Item 8
Chunk 103
---
 revenue growth rates and discount rate required specialized skills and knowledge.

The following are the primary procedures we performed to address this critical audit matter. We evaluated the design and tested the operating effectiveness of certain internal controls related to the Company’s calculation of the fair value of its reporting unit. This included controls related to the development of assumptions for forecasted revenue growth rates and discount rate. We evaluated the Company’s forecasted revenue growth rates by comparing them to historical actual growth rates and industry 

Pacira BioSciences, Inc.  |  2024 Annual Report on Form 10-K  |  Page F-3

data that was assessed to be relevant and reliable. We involved valuation professionals with specialized skills and knowledge, who assisted in evaluating the projected revenue growth rates by comparing them to guideline public companies and developing an independent estimate of the discount rate using inputs from publicly available market data and comparing the results to the Company's discount rate assumption.

/s/ KPMG LLPWe have served as the Company’s auditor since 2015.Short Hills, New JerseyFebruary 27, 2025

Pacira BioSciences, Inc.  |  2024 Annual Report on Form 10-K  |  Page F-4

PACIRA BIOSCIENCES, INC.

CONSOLIDATED BALANCE SHEETS

(In thousands, except share and per share amounts) December 31,20242023ASSETSCurrent assets:  Cash and cash equivalents$276,774 $153,298 Short-term available-for-sale investments207,841 125,283 Accounts receivable, net113,304 105,556 Inventories, net125,282 104,353 Prepaid expenses and other current assets21,929 21,504 Total current assets745,130 509,994 Noncurrent available-for-sale investments— 2,410 Fixed assets, net167,169 173,927 Right-of-use assets, net49,222 61,020 Goodwill— 163,243 Intangible assets, net425,970 483,258 Deferred tax assets130,376 144,485 Investments and other assets35,649 36,049 Total assets$1,553,516 $1,574,386 LIABILITIES AND STOCKHOLDERS’ EQUITY  Current liabilities:  Accounts payable$19,133 $15,698 Accrued expenses80,124 64